INTERCEPT PHARMACEUTICALS IN - NOTE 3.250% 7/0 Institutional Ownership

13F Institutional Holders and Ownership History from Q2 2016 to Q3 2023

Type / Class
Debt / NOTE 3.250% 7/0
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of INTERCEPT PHARMACEUTICALS IN - NOTE 3.250% 7/0 across Reporting Periods

Period Principal Value Change Price (% of par) (Median) Investors
2023 Q3 $0 $0 -$10,109,022 0
2023 Q2 $9,719,000 $10,109,022 -$86,491,702 100.49% 4
2023 Q1 $96,946,832 $96,458,698 +$4,661,082 99.25% 17
2022 Q4 $92,301,155 $90,837,870 +$10,574,603 98.02% 22
2022 Q3 $77,140,000 $76,143,830 +$562,793 97.12% 19
2022 Q2 $76,577,000 $75,591,990 -$18,743,825 97.0% 19
2022 Q1 $82,929,667 $90,481,476 +$3,530,752 92.0% 23
2021 Q4 $82,778,227 $79,161,051 -$6,465 94.68% 24
2021 Q3 $84,114,142 $77,029,805 -$293,537,003 90.18% 26
2021 Q2 $411,323,279 $370,232,428 -$21,064,846 90.0% 33
2021 Q1 $449,991,048 $373,710,879 -$3,654,814 82.0% 41
2020 Q4 $438,570,500 $343,421,900 -$798,028 77.78% 35
2020 Q3 $469,032,500 $379,338,906 +$2,391,122 80.48% 46
2020 Q2 $445,347,500 $334,279,014 +$4,648,311 75.26% 45
2020 Q1 $443,068,500 $361,104,934 +$7,505,037 81.16% 49
2019 Q4 $433,084,208 $438,750,527 +$11,216,577 100.84% 44
2019 Q3 $428,672,000 $370,347,732 +$12,065,929 86.02% 44
2019 Q2 $417,577,832 $386,205,424 -$39,428,176 89.21% 48
2019 Q1 $454,934,000 $451,601,140 +$30,882,740 99.15% 48
2018 Q4 $424,884,000 $389,544,000 +$9,159,433 92.31% 43
2018 Q3 $418,404,000 $422,410,019 +$54,142,363 101.01% 44
2018 Q2 $358,964,000 $315,021,000 -$1,913,901 87.88% 43
2018 Q1 $363,982,000 $292,060,000 +$2,559,573 80.5% 43
2017 Q4 $366,010,000 $293,730,000 -$19,654,894 80.0% 45
2017 Q3 $391,549,000 $304,651,000 -$475,345 77.74% 49
2017 Q2 $378,223,000 $369,328,000 +$6,723,454 97.64% 39
2017 Q1 $372,201,000 $347,788,000 -$28,762,418 93.26% 40
2016 Q4 $405,912,000 $363,347,000 -$11,353,945 89.62% 43
2016 Q3 $407,063,000 $456,083,000 +$444,891,318 112.01% 43
2016 Q2 $10,000,000 $10,301,000 +$10,301,000 103.01% 1